—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Orion Oyj B (ORNBV.HE) — the peer cohort

As of 2026-10-27 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Orion Oyj B ranks 6 of 11 in its cohort on the Closelooknet composite (63/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ORNBV.HE Orion Oyj B 63 89 84 32 ok 2.1%
LLY Eli Lilly and Company 65 83 91 27 watch 3.2%
ORNAV.HE Orion Oyj A 63 89 84 32 ok 2%
AMGN Amgen Inc 57 89 85 41 watch 1.4%
SAN.PA Sanofi SA 57 46 70 59 neutral 13.6%
NVO Novo Nordisk A/S 55 23 86 74 watch 36.8%
AZN.L AstraZeneca PLC 52 41 74 47 info 17.1%
BION.SW BB Biotech AG 74 65 96 81 info 11.8%
ANN.AU Ansell Ltd 64 96 48 57 ok 1.1%
ARGX.BR Argen-X 64 72 76 30 info 15.4%
ONC BeiGene, Ltd. 64 82 65 31 ok 5.8%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-27

Quick answers

Who are Orion Oyj B's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Eli Lilly and Company (LLY), Orion Oyj A (ORNAV.HE), Amgen Inc (AMGN), Sanofi SA (SAN.PA), Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN.L), BB Biotech AG (BION.SW), Ansell Ltd (ANN.AU) and others.

How does ORNBV.HE score against its peers?

Orion Oyj B's composite reads 63/100, ranking 6 of 11 in its cohort as of 2026-10-27; the cohort's highest composite is BB Biotech AG at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.